In addition, significant reductions in parameters were observed in patients with hypertriglyceridemia (TG ≧150 mg/dL, n = 6), those with high risk for bone resorption (NTX 35.3–54.3 nmol/L BCE/mM.Cre, n = 32) or fracture (NTX >54.3 nmol/L BCE/mM.Cre, n = 5), and all the women with abnormal parathyroid hormone levels (PTH >65 pg/mL, n = 15) at the baseline. The gene discussed is PTH; the disease is hypertriglyceridemia.